FN2 Earnings Intelligence
Amgen Inc. ratios (quarterly)
Amgen Inc. (AMGN) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $8,810 | $8,028 | $9,445 | $12,038 | $13,989 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $8,149 | $9,179 | $9,557 | $8,618 | $10,054 | $10,046.7 | $10,253 |
| % Growth | - | - | - | - | - | 5.1% | - |
| Gross Profit | $5,181 | $6,168 | $6,475 | $5,874 | $7,243 | - | - |
| % Margin | 63.6% | 67.2% | 67.8% | 68.2% | 72.0% | - | - |
| EBITDA | $2,565 | $2,876 | $2,758 | $3,782 | $3,736 | - | - |
| % Margin | 31.5% | 31.3% | 28.9% | 43.9% | 37.2% | - | - |
| Net Income | $1,730 | $1,432 | $3,216 | $1,819 | $2,375 | - | - |
| % Margin | 21.2% | 15.6% | 33.7% | 21.1% | 23.6% | - | - |
| Diluted EPS | $3.20 | $2.65 | $5.93 | $3.34 | $4.37 | $5.79 | $5.80 |
| % Growth | - | - | - | - | - | -2.4% | - |
| Operating Cash Flow | $1,391 | - | - | $2,189 | - | - | - |
| CapEx | $411 | - | - | $712 | - | - | - |
| Free Cash Flow | $980 | - | - | $1,477 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $8,149 | $9,179 | $9,557 | $8,618 | $10,054 | $10,046.7 | $10,253 |
| Gross Profit | $5,181 | $6,168 | $6,475 | $5,874 | $7,243 | - | - |
| EBITDA | $2,565 | $2,876 | $2,758 | $3,782 | $3,736 | - | - |
| Net Income | $1,730 | $1,432 | $3,216 | $1,819 | $2,375 | - | - |
| Diluted EPS | $3.20 | $2.65 | $5.93 | $3.34 | $4.37 | $5.79 | $5.80 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8,810 | $8,028 | $9,445 | $12,038 | $13,989 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $54,013 | $53,760 | $52,434 | $51,886 | $51,859 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,391 | - | - | $2,189 | - |
| Capital Expenditure | $411 | - | - | $712 | - |
| Free Cash Flow | $980 | - | - | $1,477 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 63.6% | 67.2% | 67.8% | 68.2% | 72.0% |
| EBITDA Margin | 31.5% | 31.3% | 28.9% | 43.9% | 37.2% |
| Net Margin | 21.2% | 15.6% | 33.7% | 21.1% | 23.6% |
| FCF Margin | 12.0% | - | - | 17.1% | - |
| Diluted EPS Growth | - | - | - | - | - |